Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Aimmune, Allen, behavior, blended, borrowing, CCPA, Celia, cellular, chemotherapy, Circuit, codified, collateralized, compromise, context, crime, CRR, database, downsizing, dubbed, Eckert, embedded, epithelial, EU, evolve, evolving, excluded, Fisher, fusion, GDPR, Gilead, hemolytic, inactivity, incremental, inline, input, insolvency, intrusion, Jazz, killing, leadership, lessee, lifted, mark, mobile, monotherapy, movement, NaN, network, obexelimab, ORR, overseeing, overspending, Patheon, pharmacokinetic, pharmacologic, plamotamab, prevalent, progressing, proliferation, rare, reject, remanded, reschedule, residual, retired, RSU, secretary, sophistication, Sr, SSP, tafasitamab, tenant, theft, Thermo, tracing, transmembrane, Umbrella, uremic, vir, VirBio, whichever, word, Yang
Removed:
ACR, admitting, AE, al, allergic, apparent, approving, area, argument, arm, array, assuming, asthma, AstraZeneca, atopic, attack, background, baseline, belimumab, Benlysta, beta, Biogen, breached, captioned, certified, Chancery, classification, College, complaint, confounding, Consulting, core, count, creation, DePinto, detectable, diarrhea, die, discomfort, diversity, Dohme, Duty, earliest, emerging, exceeded, fever, fewer, fiduciary, finalized, GlaxoSmithKline, half, headache, hypersensitivity, IgE, immunogenicity, improvement, infusion, initiating, integral, invested, IV, lawsuit, lenalidomide, Lloyd, lowest, lt, manageable, mechanism, median, mediation, Merck, modulating, nausea, neutralize, Nordisk, Novo, Nucala, numerically, observe, occurrence, optimization, oral, placebo, platelet, plc, predominant, principle, proportion, pyrexia, quickly, randomized, reaction, recapitalization, reception, reducing, Regeneron, remission, representing, rescue, responder, Rheumatology, RI, Rituxan, rituximab, robust, Rowland, scaffold, secondary, serum, Sharp, showed, small, source, statistically, threatening, thrombocytopenia, timeframe, transient, travel, underwriting, urticaria, verified, vomiting, warrant, wrongdoing, Xolair
Filing tables
Filing exhibits
Related press release
Associated XNCR transcripts
XNCR similar filings
Filing view
External links